IL17A and neoplasm: Additionally, IL-17A alters the tumor microenvironment through the induction of tissue-remodeling substances, such as MMPs, inhibition of apoptosis, promotion of angiogenesis as well as recruitment of immature myeloid cells, which can suppress the activity of CD8+ T cells [198,199,200,201,202].